标题
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 13, Issue 12, Pages 3020-3032
出版商
Informa UK Limited
发表日期
2017-10-31
DOI
10.1080/21645515.2017.1383575
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
- (2017) Carly M. Bliss et al. MOLECULAR THERAPY
- Billion-dollar project aims to prep vaccines before epidemics hit
- (2017) Declan Butler NATURE
- Nipah virus: transmission of a zoonotic paramyxovirus
- (2017) Bronwyn Anne Clayton Current Opinion in Virology
- Open-label phase I clinical trial of Ad5-EBOV in Africans in China
- (2017) Lihua Wu et al. Human Vaccines & Immunotherapeutics
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
- (2017) Christine Dahlke et al. EBioMedicine
- Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
- (2016) William E. Diehl et al. CELL
- Human Adaptation of Ebola Virus during the West African Outbreak
- (2016) Richard A. Urbanowicz et al. CELL
- A Mouse Model of Zika Virus Pathogenesis
- (2016) Helen M. Lazear et al. Cell Host & Microbe
- Multivalent and Multipathogen Viral Vector Vaccines
- (2016) Katharina B. Lauer et al. Clinical and Vaccine Immunology
- Viral vectors as vaccine platforms: from immunogenicity to impact
- (2016) Katie J Ewer et al. CURRENT OPINION IN IMMUNOLOGY
- Ebola virus vaccines – reality or fiction?
- (2016) Chad E. Mire et al. Expert Review of Vaccines
- Simian adenoviruses as vaccine vectors
- (2016) Susan J Morris et al. Future Virology
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hendra virus and Nipah virus animal vaccines
- (2016) Christopher C. Broder et al. VACCINE
- Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
- (2016) Pawan Dulal et al. VACCINE
- Status of vaccine research and development of vaccines for Nipah virus
- (2016) Benjamin A. Satterfield et al. VACCINE
- Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
- (2016) Maria Pelliccia et al. Nature Communications
- Animal models of Middle East respiratory syndrome coronavirus infection
- (2015) Neeltje van Doremalen et al. ANTIVIRAL RESEARCH
- Access to Investigational Drugs: FDA Expanded Access Programs or “Right-to-Try” Legislation?
- (2015) M. E. Blair Holbein et al. CTS-Clinical and Translational Science
- Stability of a Vesicular Stomatitis Virus–Vectored Ebola Vaccine
- (2015) Marianne Arnemo et al. JOURNAL OF INFECTIOUS DISEASES
- Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
- (2015) Anurodh Shankar Agrawal et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- How to beat the next Ebola
- (2015) Declan Butler NATURE
- Establishing a Global Vaccine-Development Fund
- (2015) Stanley A. Plotkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
- (2015) Caroline Ogwang et al. Science Translational Medicine
- Mapping the zoonotic niche of Lassa fever in Africa
- (2015) Adrian Q. N. Mylne et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
- (2014) Susanne H. Hodgson et al. JOURNAL OF INFECTIOUS DISEASES
- Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates
- (2014) D. K. Clarke et al. JOURNAL OF VIROLOGY
- Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection
- (2014) A. S. Cockrell et al. JOURNAL OF VIROLOGY
- Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis
- (2014) Quan Liu et al. LANCET INFECTIOUS DISEASES
- A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS
- (2014) Eoghan de Barra et al. PLoS One
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins
- (2014) Blair L. DeBuysscher et al. VACCINE
- Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
- (2014) Darryl Falzarano et al. PLoS Pathogens
- A treatment for and vaccine against the deadly Hendra and Nipah viruses
- (2013) Christopher C. Broder et al. ANTIVIRAL RESEARCH
- Mice Lacking Functional STAT1 Are Highly Susceptible to Lethal Infection with Lassa Virus
- (2013) N. E. Yun et al. JOURNAL OF VIROLOGY
- A decade after SARS: strategies for controlling emerging coronaviruses
- (2013) Rachel L. Graham et al. NATURE REVIEWS MICROBIOLOGY
- Pneumonia from Human Coronavirus in a Macaque Model
- (2013) Vincent J. Munster et al. NEW ENGLAND JOURNAL OF MEDICINE
- An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
- (2013) Juan C Zapata et al. Virology Journal
- Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
- (2013) Katie J. Ewer et al. Nature Communications
- Vaccines for viral hemorrhagic fevers—progress and shortcomings
- (2013) Darryl Falzarano et al. Current Opinion in Virology
- Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
- (2013) Stephan Ölschläger et al. PLoS Pathogens
- Animal models for Ebola and Marburg virus infections
- (2013) Eri Nakayama et al. Frontiers in Microbiology
- Type I Interferon Signaling Protects Mice From Lethal Henipavirus Infection
- (2012) Kévin P. Dhondt et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
- (2012) Susanne H. Sheehy et al. PLoS One
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
- (2012) Richard D. Antrobus et al. PLoS One
- A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge
- (2012) K. N. Bossart et al. Science Translational Medicine
- Lassa Fever in West Africa: Evidence for an Expanded Region of Endemicity
- (2012) N. Sogoba et al. Zoonoses and Public Health
- Immune Responses and Lassa Virus Infection
- (2012) Marion Russier et al. Viruses-Basel
- Advanced Vaccine Candidates for Lassa Fever
- (2012) Igor Lukashevich Viruses-Basel
- Argentine hemorrhagic fever vaccines
- (2011) Ana Ambrosio et al. Human vaccines & immunotherapeutics
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
- (2011) Susanne H Sheehy et al. MOLECULAR THERAPY
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge
- (2011) Jackie Pallister et al. VACCINE
- Current Good Manufacturing Practice Production of an Oncolytic Recombinant Vesicular Stomatitis Viral Vector for Cancer Treatment
- (2010) L.J. Ausubel et al. HUMAN GENE THERAPY
- Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model
- (2010) D. A. Bente et al. JOURNAL OF VIROLOGY
- Capsid-Incorporation of Antigens into Adenovirus Capsid Proteins for a Vaccine Approach
- (2010) Qiana L. Matthews MOLECULAR PHARMACEUTICS
- Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection
- (2010) Thomas W. Geisbert et al. PLoS One
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs
- (2010) Xiaohong Jiang et al. VACCINE
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
- (2009) Craig W. Day et al. VIROLOGY
- A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
- (2009) Katharine N. Bossart et al. PLoS Pathogens
- Global trends in emerging infectious diseases
- (2008) Kate E. Jones et al. NATURE
- A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
- (2008) Thérèse Couderc et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now